tion (8 ).
In myelopoiesis, ALP production in neutrophils is induced by G-CSF, and NAP is released into the bloodstream, perhaps through leakage of ALP from damaged or dead neutrophils. Fossa et al. (9 ) reported leukocytosis and increased serum ALP in response to G-CSF treatment and suggested that increased serum ALP activity was related to release of the enzyme from the increased numbers of leukocytes. Neutrophils were reported to be the source of increased serum ALP activity in experiments in which G-CSF was administered to rats (10 ).
Our present results reflect a common phenomenon caused by disease, such as granulocytic leukemia or PV. We conclude that neutrophils may be an important source of increased serum ALP activity or bone-type ALP isoenzyme. Increased bone-type ALP should not be misdiagnosed as representing a pathologic condition, such as thyroid disease (hyperthyroidism), in which there is osteomalacia; hyperparathyroidism (either primary or secondary); chronic renal failure with renal osteodystrophy; diabetes mellitus with osteomyelitis; or metastatic cancer in which there is osteoblastic activity, such as prostate cancer. The present report describes indirect evidence that NAP might explain high bone-type ALP activity in patients without osteoblastic bone disease. Direct evidence is needed of the biochemical and immunochemical properties of ALP in the sera of patients with leukocytosis. signed for this purpose, is a common method to determine Hb A 1c values relative to total Hb A. Alternatively, immunoassays or boronate affinity chromatography are used. The influence of Hb variants on HPLC assays is well recognized, and the interaction of numerous Hb variants have been described previously (3 ) . We report here the findings in a case of Hb Stanleyville II that caused gross overestimation of Hb A 1c in our routine HPLC assay.
Case report. A 54-year-old man was transferred from the department of neurology to our department of internal medicine (gastroenterology, endocrinology, and diabetology) with the diagnosis of a diabetic polyneuropathy. The patient suffered from anesthesia and dysesthesia in both legs. He had been treated with 300 mg of alphaliponic acid twice a day. Within a year he had lost 30 kg of weight through diet and sports to improve his blood glucose concentrations. However, in the last few months his general condition had deteriorated with the symptoms mentioned above. We saw a 54-yearold man (height, 186 cm; weight, 75 kg) in moderately good general condition. Apart from the neurologic findings there were no other pathologies evident in the physical examination. The blood glucose ranged from 1 to 1.80 g/L under an intensive insulin therapy. The Hb A 1c value, expected to be Ͻ7% under insulin treatment, was 37.9% in one sample and 39.4% in another, both assayed by HPLC.
HPLC was performed on a Variant hemoglobin testing system with a standardized Hemoglobin A 1c Program (Variant; Bio-Rad). Briefly, whole blood is hemolyzed by addition of an acidic hemolysis solution. The hemoglobin solution is automatically injected on a cation-exchange column at 3-min intervals and eluted by a buffer gradient of increasing ionic strength. The hemoglobin content is measured photometrically in a flow cell at 415 nm. The resulting chromatograph (absorbance against time) is printed, and the different peaks are identified according to their elution times. Under these conditions, the patient sample gave the following results: Hb A 0 ϭ 55.2%; Hb A 1c ϭ 39.4%. Additionally, there was a peak labeled "unknown", accounting for another 4.1% (Fig. 1) . These results were considered improbable.
For further investigation, hemoglobin electrophoresis and genotyping were performed. Genomic DNA was extracted from peripheral blood by the NucleoSpin ® Blood QuickPure Kit (Macherey-Nagel). The hemoglobin ␣1 gene (HBA1) was amplified by use of the Expand High Fidelity PCR System (Roche) with 0.4 M each of primers C10 (5Ј-GATG-CACCCACTGGCACTCCT-3Ј) and BHB1 (5Ј-CCATTGTTGGCACATT-CCGGGAYA-3Ј, where Y is C or T). The amplified PCR product was purified by use of the High Pure PCR Product Purification Kit (Roche). Cycle sequencing of the purified PCR product was performed with the Big Dye Terminator (Ver. 1.1) Cycle Sequencing Kit (Applied Biosystems). The sequencing reactions were purified from residual dye terminators and run on an ABI Prism 3100 genetic analyzer. Analysis was performed with the Sequencing Analysis and Sequence Navigator Software (Applied Biosystems).
Hemoglobin genotyping revealed a point mutation of the HBA1 gene at codon 78 (lysine for asparagine; N78K), which is characteristic for Hb Stanleyville II (4 ). Bearers of Hb Stanleyville II are clinically normal. Hb Stanleyville II is not uncommon in some regions of Africa, but has only once been reported in a family of European descent (5 ) . The index patient is of German origin.
To obtain a reliable value for the patient, we sent the blood to a neighboring laboratory where Hb A 1c is measured by immunoassay (Roche Tinaquant; Roche). In this test, Hb A 1c was 6.31%, 6.25%, and 6.37% (triplicate measurement from one blood sample).
We conclude that clinicians and laboratory staff should be made aware of the limitations of Hb A 1c measurement arising from hemoglobin variants. The Hb A 1c value in this case was clearly improbable, but a less pronounced false increase might To the Editor: Hemoglobin (Hb) is the major erythrocyte protein, and measurement of free Hb in serum can be used as a marker of hemolysis. Classically, cyanohemoglobin spectrometry and immunonephelometric methods have been used for assaying free Hb in serum (1, 2 ) .
Hb metabolism partly occurs in tissue macrophages, which can engulf senescent erythrocytes (extravascular hemolysis) or take up Hb released from ruptured erythrocytes (intravascular hemolysis) and immature erythrocytes in the bone marrow. Because of the oxidative and toxic properties of the iron-containing heme in Hb, Hb is complexed by the plasma protein haptoglobin (Hp). Hp is involved in promoting the clearance of plasma Hb because Hp strongly binds free Hb and is depleted during increased hemolysis. Hp is a positive acute-phase protein and is characterized by molecular heterogeneity with 3 major phenotypes: Hp 1-1, Hp 2-2, and the heterozygous Hp 2-1 (3 ). Recent findings demonstrated that complexes of Hb and multimeric Hp 2-2 exhibit higher functional affinity for the Hb scavenger receptor CD163 on macrophages, which is an acute-phase-regulated transmembrane protein produced exclusively in monocytes (low production) and tissue macrophages (high production) (4 ) . The role of the Hp polymorphism in the elimination of free Hb also has consequences in atherosclerosis: heme transfer from methemoglobin to LDLs is almost completely inhibited by Hp 1-1 and only partially by Hp 2-2 (5 ). Increased concentrations of cell-free Hb lead to the consumption of nitric oxide and clinical sequelae (6 ).
Measured free Hb values also depend on venipuncture conditions and the skillfulness of the phlebotomist (2 ). We therefore investigated whether Hp phenotype affects reference values for free Hb.
We assayed blood samples from 90 healthy persons (45 males, 45 females). Free Hb was measured immunonephelometrically by the method of Lammers et al. (2 ) . Hp phenotypes were determined by starch-gel electrophoresis as described previously (7 ), and Hp concentrations were measured by fixed-time immunonephelometry on a BN II nephelometer (Behringwerke AG) and are reported according to IFCC guidelines (8, 9 ). The presence of an acute-phase reaction was excluded by measurement of serum C-reactive protein.
Persons with C-reactive protein concentrations Ͼ6 mg/L were excluded from the study.
The highest free Hb concentrations were in Hp 1-1 individuals (P Ͻ0.05, Kruskal-Wallis; Fig. 1 ). Free Hb concentrations are 61% lower in persons with the Hp 2-2 than in those with the Hp 1-1 phenotype. In Hp 1-1 and 2-1 individuals, the free Hb concentration was positively correlated with the Hp concentration (r ϭ 0.30; P ϭ 0.03), whereas free Hb was not correlated with Hp concentration in Hp 2-2 individuals (r ϭ Ϫ0.003; P ϭ 0.99). The lower serum free Hb concentrations and absence of a correlation between Hb and Hp concentrations in Hp 2-2 individuals support an alternative clearance mechanism in the Hp 2-2 phenotype. The present ‫,ء‬ P Ͻ0.01 (Kruskal-Wallis).
